相关实验视频

Updated: Feb 28, 2026

Author Spotlight: Purifying High-Quality Tubulin to Study Protein Dynamics and Therapeutic Applications

Author Spotlight: Purifying High-Quality Tubulin to Study Protein Dynamics and Therapeutic Applications

Published on: October 11, 2024

通过结构导向设计发现基于的原抑制剂

Nicolás Osses-Bagatello¹, Esteban Rocha-Valderrama², José Ortega-Campos²

¹Instituto Universitario de Investigación y Desarrollo Tecnológico, Universidad Tecnológica Metropolitana, Santiago 8940577, Chile.

|February 27, 2026

概括

研究人员设计了一种新的,NH2-P14-COOH,通过抑制素聚合,选择性地向癌细胞. 这种可以作为一种更安全,更有效的癌症治疗剂,并减少副作用.

科学领域:

生物化学生物化学
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

图布林是癌症,抗寄生虫和神经退行性疾病治疗的关键标.
现有的结结素药物面临着诸如副作用,生物可用性差,特异性有限等挑战.
基于的疗法通过调节蛋白质-蛋白质相互作用来提高选择性和安全性的潜力.

研究的目的:

设计和评估针对tubulin的新型基药剂.
为了识别具有强大的抗真菌活性和改进安全配置文件的.
探索微管向剂的结构导向体设计.

主要方法:

综合计算-实验方法.
分子对接,分子动力学模拟和MM-GBSA自由能量计算.
设计和评估来自αβ-氨酸二聚体接口的14个.

主要成果:

NH2-P14-COOH 显示出对管聚合物的强烈抑制 (IC50 = 11.24 ± 3.82 μM).
NH2-P14-COOH对NCI-H1299肺癌细胞表现出选择性细胞毒性 (IC50 = 45.64 ± 3.20μM). 由于它具有抗癌性,因此它可以对肺癌细胞产生选择性细胞毒性.
NH2-P14-COOH对非癌性EA.hy926细胞 (IC50 > 100μM) 和诱导的亡没有显著的毒性.

结论:

NH2-P14-COOH是一种具有良好的治疗指数的选择性抗菌素.
结构导向设计是开发新型微管向剂的可行策略.
在癌症治疗中,NH2-P14-COOH具有降低非目标毒性的潜力.

关键词:

基于的抑制剂基于的抑制剂结构导向设计是指导设计的.氨酸的聚合聚合.

更多相关视频

Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation

Constructing Thioether/Vinyl Sulfide-tethered Helical Peptides Via Photo-induced Thiol-ene/yne Hydrothiolation

Published on: August 1, 2018

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

相关概念视频

Drugs that Destabilize Microtubules

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...